Pharmaron Beijing Co., Ltd. 300759.SZ Stock
Pharmaron Beijing Co., Ltd. Price Chart
Pharmaron Beijing Co., Ltd. 300759.SZ Financial and Trading Overview
Pharmaron Beijing Co., Ltd. stock price | 19.16 CNY |
Previous Close | 47.37 CNY |
Open | 47.47 CNY |
Bid | 47.97 CNY x 0 |
Ask | 47.98 CNY x 0 |
Day's Range | 47 - 48.47 CNY |
52 Week Range | 43.24 - 114.14 CNY |
Volume | 18.47M CNY |
Avg. Volume | 15.61M CNY |
Market Cap | 53.06B CNY |
Beta (5Y Monthly) | 0.692411 |
PE Ratio (TTM) | 37.178295 |
EPS (TTM) | 0.9 CNY |
Forward Dividend & Yield | 0.45 (0.99%) |
Ex-Dividend Date | June 14, 2022 |
1y Target Est | 60.6 CNY |
300759.SZ Valuation Measures
Enterprise Value | 60.33B CNY |
Trailing P/E | 37.178295 |
Forward P/E | 21.127752 |
PEG Ratio (5 yr expected) | 0.81 |
Price/Sales (ttm) | 4.8733277 |
Price/Book (mrq) | 5.2034283 |
Enterprise Value/Revenue | 5.541 |
Enterprise Value/EBITDA | 25.671 |
Trading Information
Pharmaron Beijing Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.692411 |
52-Week Change | -45.30% |
S&P500 52-Week Change | 20.43% |
52 Week High | 114.14 CNY |
52 Week Low | 43.24 CNY |
50-Day Moving Average | 48.4 CNY |
200-Day Moving Average | 59.39 CNY |
300759.SZ Share Statistics
Avg. Volume (3 month) | 15.61M CNY |
Avg. Daily Volume (10-Days) | 15.62M CNY |
Shares Outstanding | 990.2M |
Float | 729.71M |
Short Ratio | N/A |
% Held by Insiders | 50.73% |
% Held by Institutions | 23.92% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.3 |
Trailing Annual Dividend Yield | 0.63% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.36119998 |
Last Split Factor | 1.5:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.53% |
Operating Margin (ttm) | 16.15% |
Gross Margin | 37.14% |
EBITDA Margin | 21.58% |
Management Effectiveness
Return on Assets (ttm) | 5.53% |
Return on Equity (ttm) | 13.55% |
Income Statement
Revenue (ttm) | 10.89B CNY |
Revenue Per Share (ttm) | 9.22 CNY |
Quarterly Revenue Growth (yoy) | 29.50% |
Gross Profit (ttm) | N/A |
EBITDA | 2.35B CNY |
Net Income Avi to Common (ttm) | 1.47B CNY |
Diluted EPS (ttm) | 1.29 |
Quarterly Earnings Growth (yoy) | 39.80% |
Balance Sheet
Total Cash (mrq) | 2.55B CNY |
Total Cash Per Share (mrq) | 2.14 CNY |
Total Debt (mrq) | 6.15B CNY |
Total Debt/Equity (mrq) | 54.59 CNY |
Current Ratio (mrq) | 1.667 |
Book Value Per Share (mrq) | 9.217 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.26B CNY |
Levered Free Cash Flow (ttm) | -1313709824 CNY |
Profile of Pharmaron Beijing Co., Ltd.
Country | China |
State | N/A |
City | Beijing |
Address | 6 Taihe Road |
ZIP | 100176 |
Phone | 86 10 5733 0087 |
Website | https://www.pharmaron.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 19481 |
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion solutions; and in vitro biology and in vivo pharmacology, safety assessment, and the U.S. laboratory services. The company also provides process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and radiolabelled science services and early stage clinical trial services, as well as clinical research and site management services. It also provides business development; and contract research, development, and manufacturing services for pharmaceutical products. The company was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Q&A For Pharmaron Beijing Co., Ltd. Stock
What is a current 300759.SZ stock price?
Pharmaron Beijing Co., Ltd. 300759.SZ stock price today per share is 19.16 CNY.
How to purchase Pharmaron Beijing Co., Ltd. stock?
You can buy 300759.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharmaron Beijing Co., Ltd.?
The stock symbol or ticker of Pharmaron Beijing Co., Ltd. is 300759.SZ.
Which industry does the Pharmaron Beijing Co., Ltd. company belong to?
The Pharmaron Beijing Co., Ltd. industry is Biotechnology.
How many shares does Pharmaron Beijing Co., Ltd. have in circulation?
The max supply of Pharmaron Beijing Co., Ltd. shares is 1.62B.
What is Pharmaron Beijing Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Pharmaron Beijing Co., Ltd. PE Ratio is 21.28888900 now.
What was Pharmaron Beijing Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Pharmaron Beijing Co., Ltd. EPS is 0.9 CNY over the trailing 12 months.
Which sector does the Pharmaron Beijing Co., Ltd. company belong to?
The Pharmaron Beijing Co., Ltd. sector is Healthcare.